Yea Ji-Hye, Jo Chris Hyunchul
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Institute for Cell Engineering, Johns Hopkins University, Baltimore, MD, USA.
Clin Shoulder Elb. 2025 Mar;28(1):49-59. doi: 10.5397/cise.2024.00626. Epub 2025 Feb 17.
Mesenchymal stem cells (MSCs) have shown potential in regenerative medicine. In the present study the effects of MSC dosage and recipient sex on tendon regeneration were evaluated.
A full-thickness tendon defect (FTTD) was created on supraspinatus tendons (SSTs) of rats and cryoprotective solution (CPS) and MSCs (0.05, 0.1 and 0.5 million MSCs [M-MSC] for female groups and 1.0 M-MSC for both female and male groups) were applied. After 2 and 4 weeks, macroscopic and histological evaluations were performed.
Total macroscopic scores were improved in all MSC groups compared with the CPS group, with no significant differences among the MSC groups. Furthermore, all MSC groups had lower total degenerative scores than the CPS group; however, only 0.1 M-MSC, 0.5 M-MSC, and 1 M-MSC groups showed significantly improved hyalinization compared with the CPS group at 4 weeks. Collagen organization and coherence were higher in all MSC groups than in the CPS group at both 2 and 4 weeks; however, 0.5 M-MSC and 1 M-MSC groups scored better than the 0.05 M-MSC group at 4 weeks. Heterotopic matrix analysis revealed smaller glycosaminoglycan (GAG)-rich areas in the 0.1 M-MSC, 0.5 M-MSC, and 1 M-MSC groups compared with the CPS group at 4 weeks. Overall, macroscopic and histological evaluations were not significantly different between female and male groups except for GAG-rich area.
The MSC dosage affected collagen and heterotopic matrix formation in a FTTD rat model; however, the efficacy of MSCs (1.0 M dose) in collagen regeneration was not affected based on the sex of the recipient. Level of evidence: I.
间充质干细胞(MSCs)在再生医学中已显示出潜力。在本研究中,评估了MSC剂量和受体性别对肌腱再生的影响。
在大鼠的冈上肌腱(SSTs)上制造全层肌腱缺损(FTTD),并应用冷冻保护溶液(CPS)和MSCs(雌性组分别为0.05、0.1和0.5百万个MSCs [M-MSC],雌性和雄性组均为1.0 M-MSC)。在2周和4周后,进行宏观和组织学评估。
与CPS组相比,所有MSC组的总宏观评分均有所改善,MSC组之间无显著差异。此外,所有MSC组的总退变评分均低于CPS组;然而,在4周时,只有0.1 M-MSC、0.5 M-MSC和1 M-MSC组与CPS组相比,透明化有显著改善。在2周和4周时,所有MSC组的胶原蛋白组织和连贯性均高于CPS组;然而,在4周时,0.5 M-MSC和1 M-MSC组的评分优于0.05 M-MSC组。异位基质分析显示,在4周时,0.1 M-MSC、0.5 M-MSC和1 M-MSC组富含糖胺聚糖(GAG)的区域比CPS组小。总体而言,除富含GAG的区域外,雌性和雄性组之间的宏观和组织学评估无显著差异。
在FTTD大鼠模型中,MSC剂量影响胶原蛋白和异位基质的形成;然而,基于受体性别,MSCs(1.0 M剂量)在胶原蛋白再生中的疗效不受影响。证据水平:I。